Countries World

Aspen Neuroscience Secures $115 Million Series C to Advance Personalised Cell Therapy for Parkinson’s Disease

Aspen Neuroscience, Inc., a clinical-stage biotechnology company pioneering autologous regenerative therapies,  announced the closing of a $115 millio...

 November 21, 2025 | News

Abbott to Acquire Exact Sciences for $21 Billion to Transform Cancer Diagnostics

Acquisition adds a new growth vertical to Abbott's already high single-digit growth profile, gaining leadership in the fast-growing $60 billion U.S. canc...

 November 21, 2025 | News

Accord BioPharma Gains FDA Approval for Two Denosumab Biosimilars to Expand Access to Osteoporosis and Cancer Related Bone Care

Products will treat osteoporosis and skeletal-related events from certain types of bone cancer, expanding the company's biosimilar portfolio Accord BioPha...

 November 21, 2025 | News

Hoth Therapeutics Joins NVIDIA Connect Program to Advance AI Driven Drug Discovery

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on developing breakthrough therapeutics announced that it h...

 November 21, 2025 | News

ReviR Therapeutics Wins CIRM Grant to Advance First in Class Dual Target Therapy for Huntington’s Disease

ReviR Therapeutics, a biotech company focused on developing innovative treatments for neurogenetic diseases, announced  that it has been awarded a $4....

 November 21, 2025 | News

CRScube Acquires Mednet to Build a Unified Global eClinical Platform Across Asia and North America

 CRScube has announced the successful acquisition of Mednet, marking a key milestone in its global strategic growth and expansion into the North Ameri...

 November 20, 2025 | News

Nona Biosciences Enters License Agreement with Pfizer to Advance Global Antibody Discovery

Nona Biosciences, a global biotechnology company providing integrated solutions for biological drug discovery and development from I to I® (Idea t...

 November 20, 2025 | News

Tsingke Biotech Showcases Breakthrough Speed in Protein and Antibody Development at PEGS Europe 2025

At PEGS Europe 2025, one of the industry's premier gatherings for innovation in protein and antibody engineering, Tsingke Biotech highlighted its latest ac...

 November 20, 2025 | News

YolTech Therapeutics Receives FDA Clearance to Begin Pivotal Trial for In Vivo Gene Editing Therapy in PH1

YolTech Therapeutics, a clinical-stage biotechnology company developing next-generation in vivo gene editing therapies, today announced that the U.S. Food ...

 November 20, 2025 | News

Qure.ai Integrates Its Lung Cancer AI Suite into Microsoft’s Precision Imaging Network to Advance Early Diagnosis

Qure.ai, global leader in digital healthcare,  announced its collaboration with Microsoft. Qure.ai will onboard its end-to-end lung cancer d...

 November 20, 2025 | News

Bio Techne Licenses AI Designed NovoBody Duo Molecules Under Exclusive Agreement With Monod Bio

Partnership strengthens Bio-Techne's leadership in AI-enabled protein innovation NovoBody™ Duo molecules offer multi-specific binding capabilities...

 November 19, 2025 | News

AbbVie Secures Approval for EPKINLY in Combination With R2 as the First Bispecific Therapy for Relapsed or Refractory Follicular Lymphoma

   EPKINLY plus rituximab and lenalidomide (EPKINLY + R2) is now the first and only bispecific antibody combination therapy available f...

 November 19, 2025 | News

Thermo Fisher Opens Advanced Therapies Collaboration Center In Philadelphia To Accelerate Cell And Gene Therapy Development

New state-of-the-art facility in Philadelphia provides integrated lab and collaboration space along with tailored guidance to help move advanced therapies ...

 November 19, 2025 | News

Shanghai Henlius and Organon Achieve FDA Approval for POHERDY, First Pertuzumab Biosimilar in the US

Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN)  announced that the US Food and Drug Administration (FDA) has approved the Biologics...

 November 19, 2025 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close